Design to come?

WP_Post Object
(
    [ID] => 7314
    [post_author] => 3
    [post_date] => 2025-10-30 10:28:32
    [post_date_gmt] => 2025-10-30 15:28:32
    [post_content] => 
    [post_title] => Intensity Therapeutics, Inc. Announces Publication of Clinical Results of INT230-6 for the Treatment of Metastatic or Refractory Cancers in eBioMedicine, a Lancet Discovery Science Journal
    [post_excerpt] => 
    [post_status] => publish
    [comment_status] => closed
    [ping_status] => closed
    [post_password] => 
    [post_name] => intensity-therapeutics-inc-announces-publication-of-clinical-results-of-int230-6-for-the-treatment-of-metastatic-or-refractory-cancers-in-ebiomedicine-a-lancet-discovery-science-journal
    [to_ping] => 
    [pinged] => 
    [post_modified] => 2025-10-30 10:28:32
    [post_modified_gmt] => 2025-10-30 15:28:32
    [post_content_filtered] => 
    [post_parent] => 0
    [guid] => https://vcapital.com/?post_type=news&p=7314
    [menu_order] => 0
    [post_type] => news
    [post_mime_type] => 
    [comment_count] => 0
    [filter] => raw
)